07:52 AM EDT, 09/25/2024 (MT Newswires) -- Emergent Biosolutions' ( EBS ) shares were up 12% in Wednesday's premarket session after saying it received approximately $400 million in orders for its smallpox and mpox vaccine products.

The biotech firm said it will deliver the treatments, which include its ACAM2000 smallpox vaccine, for the remainder of 2024 and 2025.

Price: 6.84, Change: +0.73, Percent Change: +11.95